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INTRODUCTION 
 Obstructive sleep apnea is the most prevalent of sleep    disordered   
breathing. Obstructive sleep apnea affects 24% of men, 9% of women in 
the general population. An estimated 82% of men 92% of women with 
moderate to severe obstructive sleep apnea have not been diagnosed. 
In OSA repeated episodes of partial and complete collapse cause a 
reduction or total cessation of airflow during sleep resulting in oxygen 
desaturation and arousals from sleep. OSA leads to excessive   daytime 
sleepiness, unrefreshing sleep, poor concentration and fatigue. 
          OSA is a serious condition that diminishes quality of life and is also  
associated  with many  co-morbidities.  Patients with OSA will have 
increased incidence of coronary artery disease, systemic hypertension, 
congestive cardiac failure, cerebrovascular disease, gastroesophageal 
reflux disease. The average life span of a patient with untreated OSA is 
reduced. 
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AIM OF STUDY 
To   test the performance of STOP-BANG QUESTIONNAIRE for 
the diagnosis of  Obstructive sleep apnea in preoperative patients 
 
OBJECTIVE OF THE STUDY: 
To validate The STOPBANG QUESTIONNAIRE by using 
POLYSOMNOGRAPHY as a gold standard test 
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ANATOMY OF AIRWAY: 
 
 
 
 
 
 
 
 
 
 
Upper airway is the common pathway for Gastrointestinal tract, 
Respiratory system and Phonatory system.  
 
Usually it is divided into three parts 
1. Nasopharynx. 
2. Oropharynx. 
3.  Hypopharynx. 
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NASOPHARYNX: 
BOUNDARIES: 
Superiorly   -  posterior margin of nasal turbinate  
Inferiorly         - soft palate 
Contents   - posterior wall contains adenoids in  
     children 
Adenoid inflammation leads to partial obstruction to upper airway. 
 
SOFT PALATE 
It is a vertical flap like structure 
 
BOUNDARIES 
Superiorly     -  Posterior edge of hard palate 
Inferiorly      - Uvula 
 
INNERVATION:   
All the muscles of soft palate get innervation from Pharyngeal 
branch of  Vagus nerve except tensor veli palatini which is innervated by  
medial pterygoid nerve. 
                             
 
5 
 
          Any elevation or swelling in the posterior portion of the soft palate 
towards the posterior pharyngeal wall causes enlargement of oral cavity 
during deglutition and thereby produces narrowing of Nasopharynx. 
 
OROPHARYNX: 
Oropharynx extends from soft palate to epiglottis. 
BOUNDARIES: 
Anteriorly by posterior part of tongue and soft palate   
Posteriorly by constrictors of   Pharynx  
Laterally by Extrinsic muscles of the Tongue, muscles of soft palate, 
larynx and also by pharyngeal constrictors. 
Oropharynx   is the most common site of airway collapse in 
Obstructive sleep apnea, which usually occurs during REM sleep. 
 
RETROPALATAL AREA: 
It contains  
1.  Palatine tonsil. 
2. Parapharyngeal pad of fat. 
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TONGUE: 
It consists of Extrinsic and Intrinsic muscles. 
 
Extrinsic muscles are  
1. Genioglossus. 
2. Hyoglossus. 
3. Palatoglossus. 
4. Styloglossus. 
 
Intrinsic muscles are: 
1. Superior longitudinal 
2.  Inferior longitudinal 
3.  Transverse 
4.  Vertical 
  
INNERVATION:   
SENSORY SUPPLY: 
Anterior 2/3 of tongue   - Chorda tympani branch of facial  
      Nerve. 
 Posterior 1/3 of tongue   - Glossopharyngeal nerve 
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MOTOR INNERVATION: 
All extrinsic muscles of tongue are supplied by Hypoglossal nerve 
except palatoglossus which is innervated by vagus nerve. 
          The size of the tongue is an important risk factor for OSA. An 
increase in size of type II muscle fibres is seen in obstructive sleep apnea 
patients compared to normal individuals. 
Hypoglossal nerve is the main component in the motor control of 
upper airway dilatation. The muscle fibres in the posterior part of tongue 
are fatigue resistant which maintains the forward tongue position and 
preventing its collapse into the retroglossal area. 
          Patients with OSA have minimum smaller airway area in the 
retropalatal region particularly in lateral dimension. The volume of tongue 
and lateral walls independently increase the risk of OSA. 
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Retropalatal airway closure:  
Patients will have higher percentage of Parapharyngeal pad of fat 
and palatal pad of fat 
 
Retroglossal airway closure: 
Patients will have increased volume of tongue and parapharyngeal 
pad of fat 
 
 
 
 
 
 
 
 
HYPOPHARYNX: 
It extends from superior border of epiglottis to the inferior border of 
cricoid cartilage. 
BOUNDARIES: 
Anteriorly by base of tongue and epiglottis. 
Postero-laterally by inferior pharyngeal constrictor. 
Hypopharynx consists of lingual tonsil. 
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Lingual tonsil hypertrophy plays an important role in OSA in children. 
Epiglottic prolapse during inspiration can cause OSA. 
            
 
 
 
 
 
 
 
AIRFLOW DURING SLEEP 
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APNEA: 
Repeated episodes of complete cessation of airflow for 10 seconds 
or longer. 
HYPOPNEA: 
It is a significant decrease in breathing without complete cessation  
of  airflow ,it is defined as 30% decrease in airflow in conjunction  with  
4%  oxygen  desaturation . 
 
 
 
 
 
 
 
 
PATHOPHYSIOLOGY OF OSA 
The pathophysiology of OSA is multifactorial. The common 
mechanism which plays an important role in the development of OSA are 
1. Upper airway collapsibility 
2. Effects of lung volumes 
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3. Pharyngeal dilator tone 
4. Arousal response in OSA 
5. Ventilatory control stability 
6. Pharyngeal neuropathy 
 
Upper airway collapsibility: 
Airway may collapse during sleep.  
Airway collapse may due to 
Changes in transmural pressure, either decreased  
Intra-luminal pressure or increased external tissue pressure. 
Decreased longitudinal tension on the pharynx. 
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Patients with OSA have different airway compared to normal airway 
because of thicker lateral pharyngeal walls with anterior-posterior elliptical 
configuration. Airway area is also small in obstructive sleep apnea patients. 
          The threshold pressure sufficient to maintain patency of the upper 
airway is called the pharyngeal closing pressure (Pcrit). 
          Pcrit has been shown to correlate with severity of OSA. Reduction in 
weight reduces Pcrit there by maintaining patency of the airway. 
 
 
 
 
 
 
 
 
 
 
EFFECT OF LUNG VOLUMES: 
Caudal traction and elongation of the airway reduces Pcrit through 
stiffening the airway and thereby decreasing the surrounding tissue 
pressure. 
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SUPINE POSITION 
It causes reduction in lung volume in apneic patient which 
minimizes caudal traction on airway. 
 
SEMI-RECUMBENT POSITION 
It improves the caudal traction and thereby reducing 
Obstructive sleep apnea severity. 
    
 
 
 
 
 
 
 
UPPER AIRWAY DILATOR MUSCLE ACTIVITY: 
Collapsing forces related to tissue pressure and intra-luminal 
negative pressure are balanced by pharyngeal dilator muscle activity. The 
genioglossus is the largest pharyngeal dilator. The tone of genioglossus 
muscle is reduced during sleep. Apneic patients are relying on a heightened 
genioglossus to support the airway, leading to airway instability. 
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          The degree to which this occurs also depends on the sleep stage. 
Slow wave sleep has been associated with heightened genioglossus tone, 
which might be protective against OSA. During REM sleep reduction in 
tonic genioglossus activity occurs which potentiates further apneas. 
 
AROUSAL RESPONSE IN OSA: 
Most episodes of apneas are followed by arousals which are thought 
to be mediated via negative intra-thoracic pressure generation. OSA 
impairs the arousal threshold and apneic patients needed greater inspiratory 
efforts to trigger an arousal. Continuous positive airway pressure reduces 
the heightened arousal threshold in apneic patients. 
 
VENTILATORY CONTROL STABILITY: 
The feedback loop that controls the respiratory response to airway 
collapsibility and arousal can be conceptualized as Loop gain which refers 
to the magnitude of response related to intensity of input. 
          Obstructive sleep apneic patients have an elevated loop gain 
particularly those with severe OSA, which translates into an overshoot of 
Ventilatory response and arousal leading to disproportionately lower 
carbon dioxide. 
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PHARYNGEAL NEUROPATHY: 
A selective impairment of the ability to detect mechanical stimuli of 
upper airway of the patients with OSA has been diagnosed using two point 
discrimination and vibratory test .Abnormal laryngeal sensation is detected 
using Air Pressure Pulses Endoscopy in OSA. Inflammation and 
denervation affect the oral mucosa and upper airway muscles in OSA. 
 
AIRWAY OF OBSTRUCTIVE SLEEP APNEA 
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COMPLICATIONS OF OBSTRUCTIVE SLEEP APNEA: 
1. Hypoxia with compensatory polycythemia. 
2. Hypercapnia. 
3. Pulmonary hypertension. 
4. Right ventricular failure/cor-pulmonale. 
5. Systemic hypertension. 
6. Arrhythmia. 
7. Sleep Fragmentation, Excessive daytime sleepiness. 
8. Depression, Cognitive impairment. 
9. Motor vehicle accidents – 7 fold increase. 
   10. Type 2 Diabetes mellitus, Metabolic syndrome. 
 
CARDIOVASCULAR CONSEQUENCES: 
Pathophysiology of OSA is the result of three immediate events  
1.  Apnea episodes. 
2.  Arousals. 
3.  Increased respiratory efforts. 
 
APNEIC AND HYPOPNEIC EPISODES: 
OSA induced Hypoxia and Re-oxygenation cycles activate REDOX 
sensitive genes, oxidative stress, inflammatory processes, sympathetic 
nervous system and coagulation cascade all of  which can contribute to 
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endothelial dysfunction and ultimately leads to systemic hypertension, 
pulmonary hypertension, atherosclerosis, right and left ventricular systolic 
dysfunction, coronary artery disease congestive heart failure , Atrial 
fibrillation, stroke and sudden cardiac death . 
 
AROUSAL EPISODES: 
It leads to increased activation of sympathetic nervous system and 
decreased parasympathetic system activity, which results in increase in 
heart rate, left ventricular after load , myocardial oxygen consumption, 
dysrhythmias,  myocardial toxicity and apoptosis  arousal  episodes leads 
to non-restorative sleep, chronic sleep deprivation which are also 
associated with increased sympathetic nervous system activity, 
inflammation and hyper metabolic state. 
 
INCREASED RESPIRATORY EFFORTS: 
It can result in large swings in negative intra-thoracic pressure which 
are transmitted to the heart, lungs and great vessels; this transmural 
pressure leads to multiple detrimental effects. 
 
SYSTEMIC HYPERTENSION 
Hypoxia and Hypercapnia leads to increased sympathetic tone 
resulting in hypertension. It is seen in 50% of the patients with  
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Obstructive sleep apnea. About 30% of the hypertensive individuals have 
obstructive sleep apnea 
 
PULMONARY HYPERTENSION: 
Apnea causes desaturation of oxygen, increased carbon dioxide 
accumulation, resulting in acidosis which leads to pulmonary hypertension 
due to pulmonary vasoconstriction. Chronic hypertension results in right 
ventricular hypertrophy causing right ventricular failure. 
 
CARDIAC ARRHYTHMIA: 
Apnea causes Nocturnal bradycardia followed by tachycardia on 
arousal. 
          Unexplained nocturnal deaths are also common in patients with 
obstructive sleep apnea. Patients with sleep apnea have 30% higher risk of 
Myocardial infarction than normal individuals. 
 
NEUROLOGICAL CONSEQUENCES: 
EEG changes  
Slowing of EEG. 
Decrease in deeper stages of sleep. 
          Compensatory increase in lighter stage of sleep 
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Psychomotor vigilance task testing demonstrates an increase in the 
number of lapses 
OSA is associated with  
Decrease in cognition and performance 
Decrease in quality of Life 
          Mood disorder 
          Increased rate of motor vehicle collisions. 
METABOLIC DERANGEMENT: 
Insulin resistance 
Glucose intolerance 
 Dyslipidemia 
 
METABOLIC DISORDER: 
Type 2 DM 
          Metabolic syndrome 
          Central obesity 
          Non-alcoholic steatohepatitis (NASH) 
          Polycystic ovarian syndrome (PCOS) 
OSA is seen in 50% of   the patient with NASH. 
OSA is seen in 30-50% of the patients with PCOS. 
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OBESITY AND OSA: 
Obesity,  often  an  accompaniment  to  OSA,  presents  the  
anaesthesia  provider’s  first  set  of  challenges.  Deposition  of  fat  in  the  
pharyngeal  tissues  exacerbates  the  underlying  narrowness  and  
collapsibility  of  the  pharyngeal  airway. Obese patients  also  accumulate  
more  visceral  fat,  which  appears  to  affect  the  severity of  the  OSA.  
          Symptom severity correlates with weight loss and gain. 10%  gain  
in  weight  in  patients  with  OSA  led  to  a  32%  increase  in  the  
number  of  apneas  and  hypopneas  experienced  per  hour  of  sleep.   A  
modest  10%  decrease  in  weight  led to  a  26%  improvement  in  the  
AHI. Weight  loss  results  in  a  dose-dependent decrease  in  the  severity  
of  the  syndrome. 
           Apart from upper airway narrowing, fat deposition in the chest and 
abdomen contributes to OSA.  In morbidly obese patients, neck size is a 
better predictor of sleep apnea than other body anthropomorphic measures. 
Abdominal obesity may reduce lung volumes particularly in the supine 
posture and so reduce upper airway size.  Lung volume directly influences 
upper airway size during respiration.  
           Thoracic inspiratory activity causes caudal traction on trachea, 
increasing cross-sectional area. This may be reduced in obese patients as 
impaired respiratory muscle force noted in these patients. Cephalad 
movement of the trachea, as would occur with a decrease in lung volume, 
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decreases upper airway size and increases pharyngeal resistance.  Passive 
inflation of the lung producing an increase in end - expiratory lung volume 
increases the size of the retropalatal airway. 
           OSA and obesity also play a significant role in cardiovascular 
morbidity.  Obesity  increases  the  risk  of  hypertension,  heart  failure,  
stroke,  and coronary  heart  disease  .  Another common co-morbid 
condition in patients with OSA is metabolic syndrome.  This disorder is 
characterized by the clustering of concurrent metabolic conditions.  
Typically, the patient has central obesity, hypertension, diabetes, and 
dyslipidemia. Although  a  direct  link  has  yet  to  be  made  between 
metabolic  syndrome  and  OSA, about  60%  of  patients  with  OSA  have  
metabolic  syndrome  In  addition to  managing  the  consequences  of  
OSA  and  cardiovascular  morbidity,  the anaesthesia provider  must  also  
be  cognizant  of  the  end-organ  damage  that  can  
result from metabolic syndrome. 
                The development of Obesity Hypoventilation Syndrome (OHS) 
is multifactorial, with the key elements a combination of obesity (increased 
upper airway loading and reduced lung volumes), OSA, poor 
chemoreceptor function (particularly defective arousal responses to 
hypoxia) and possibly alcohol consumption (reducing upper airway tone 
and arousal responses to asphyxia). 
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It is important to stress that awake hypercapnia can occur  in obese 
patients in the absence of any smoking history or lung or muscle disease   
More recently,  leptin has been implicated in sleep –disordered breathing in 
obese subjects. Leptin replacement resulted in an increase in minute 
ventilation (awake and asleep) and increased chemosensitivity to carbon 
dioxide during sleep. These changes were independent of food intake, 
weight and CO2 production.   
Patients with OSA have higher leptin levels than subjects with 
similar obesity without OSA. In human obesity, leptin “resistance”   is 
common and leptin may act as a respiratory stimulant so that deficiency or 
resistance to the effects of leptin may promote OHS  
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POLYSOMNOGRAPHY: 
                   
 
 
 
 
 
 
 
 
 
Polysomnography is a type of sleep study. It is a multi parametric 
analysis used in the study of sleep. Polysomnography is a comprehensive 
recording of the biophysical changes that occur during sleep. Standard 
PSG consists of simultaneous recording of multiple physiologic parameters 
during a full night of sleep in a sleep laboratory with a sleep technologist 
in attendance. It should contain 6 or more hours of recording.  
The recorded PSG study is divided into 30 second periods called 
epochs for scoring purposes. During scoring each individual epoch must be 
scored for sleep stage, and any respiratory events such as apnea or 
hypopnea with or without obstruction, cardiac or limb events and 
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associated arousal. Respiratory events are scored if they last 10 seconds or 
longer. 
Sleep apnea testing can be done in several ways each with decrease 
in degree of complexity.  
Level 1 testing is Polysomnography. 
Level 2 testing is unattended PSG done at home. 
Level 3 testing is home apnea testing in combination with active graph. 
Level 4 testing uses one to two channels to monitor pulse oximetry and air 
flow. 
Overnight home oximetry is an example of level 4 sleep apnea test. 
The rules for performing and interpreting PSG are published in 
American Association of Sleep Medicine (AASM) Manual for scoring of 
sleep and associated events. The manual covers the performance and 
interpretation of Polysomnography studies and home sleep testing. 
 
USES OF POLYSOMNOGRAPHY: 
1. Used to differentiate central sleep apnea from obstructive sleep apnea. 
2. To assess the severity of OSA. 
3. To detect associated hypoventilation and hypoxia. 
4. To titrate positive airway pressure therapy. 
5. To perform follow up assessments of any implemented therapy for the 
Sleep related breathing disorder. 
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PHYSIOLOGICAL FUNCTION STUDIED DURING 
POLYSOMNOGRAPHY: 
 Electroencephalogram to measure and evaluate sleep stages. 
 Electrooculogram to measure eye movements. 
 Chin electromyogram to measure muscle tone and the presence sleep 
without atonia. 
 Limb Electromyogram to detect periodic limb movements and restless 
leg syndrome. 
 Electrocardiogram to detect dysrhythmias. 
 Upper airway sound recording to detect snoring. 
 Nasal and oral airflow via air thermal sensor to detect apnea. 
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 Nasal airflow via pressure sensor to detect hypopnea and arousals. 
 Thoraco-abdominal inductance plethysmography to detect respiratory 
effects. 
 Pulse oximeter to detect oxygen saturation/ desaturation.  
 Capnography to detect hypercarbia/hyperventilation. 
 Body position sensor to note body position effects. 
 Video recording or sleep technologist observation to detect parasomnia. 
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TYPES OF SLEEP STUDY 
Overnight diagnostic sleep studies 
1. This is the most common type of sleep study , where tiny sensors are 
used to measure the body's physiological process during sleep. 
2. Diagnostic polysomnograms (PSGs) are used to diagnose snoring, 
obstructive sleep apnoea, periodic limb movement disorder, sleep-state 
misperception, and other less common sleep disorders; they can also be 
very helpful in investigating insomnia, narcolepsy, idiopathic hyper 
somnolence and restless limb syndromes. 
3. Many of the standard sleep-laboratories use infra-red digital video 
technology to enable recording of abnormal limb movements, fits or 
seizures, and abnormal behaviours during sleep. 
 
Daytime diagnostic studies 
Daytime diagnostic sleep studies similar to overnight PSG can be 
performed in individuals who normally sleep during the day  
(such as shift-workers). 
 
CPAP Titration studies 
In patients whom CPAP treatment is recommended, a CPAP-
titration study is used to determine what CPAP pressure is required to 
control snoring and obstructive respiratory events optimally. Tiny sensors 
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similar to those used during a diagnostic sleep study are also used during a 
CPAP-titration study. 
BPAP (VPAP) and APAP Titration studies 
They are similar to CPAP-titration studies; these studies involve the 
use of bi-level positive airway pressure (BPAP, also called variable 
Positive Airway Pressure - VPAP) or Automated Positive Airway Pressure 
(APAP) technology to treat OSA. 
 
Multiple Sleep Latency Test (MSLT) 
1. MSLT is a specialised daytime sleep-study used to investigate 
narcolepsy and hyper somnolence. 
2. MSLTs are generally performed during the day, immediately 
following an overnight PSG. 
3. The test involves 4 or 5 nap periods at 2-hourly intervals throughout 
the day. 
4. Brain waves and eye movements are recorded to enable sleep-times 
and sleep- stages to be determined. 
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Maintenance of Wakefulness Test (MWT) 
This test is used to assess a patient’s ability to maintain wakefulness 
throughout the day. This test is helpful in assessing the efficacy of an 
individual’s   treatment for sleep-disorders and driving safety. MWTs are 
generally performed during the day, immediately following an overnight 
PSG.                   
It involves four, 40-minute test periods at 2-hourly intervals, 
throughout the day. Patients are required to stay awake throughout each 
test period (brain waves and eye movements are recorded to enable 
wakefulness and sleep-states to be determined). 
 
Electroencephalograms 
Many sleep laboratories uses full 28-channel EEGs in parallel with 
all overnight and daytime sleep-studies in patients with suspected epilepsy, 
nocturnal seizures, fits or 'funny turns'. EEG facilities include time-linked 
digital video recordings, so that convulsions or other abnormal movements 
during sleep. 
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RULES FOR SCORING RESPIRATORY EVENTS DURING 
POLYSOMNOGRAPHY IN ADULTS 
 
RESPIRATORY EVENT   SCORING CRITERIA 
Obstructive apnea    Apnea for >10 seconds with a > 90%   
     airflow reduction despite respiratory   
     effort. 
Central apnea   Apnea for >10 seconds with a > 90%               
airflow reduction without respiratory         
effort. 
Hypopnea     A > 30% reduction in airflow for > 10 
10 seconds associated with a ≥ 3%    
decline in oxygen saturation or arousal. 
Hypoventilation    A 10 minute period with Pco2  > 55mmHg 
or a ≥ 10mm Hg increase in Pco2 to 
≥ 50 mmHg. 
Periodic breathing    ≥ 3consecutive cycles of cheyne-stokes 
breathing with cycle length ≥ 40 secs or 
≥ 5episodes of Cheyne-stokes breathing  
in 2 hours. 
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The gold standard for diagnosis of obstructive sleep apnea is an  
overnight polysomnography.  
But Polysomnography is  
Time consuming 
Labour-intensive and  
Costly. 
 
Polysomnography requires sleep medicine specialists. They may not 
be readily available in most of the hospitals and medical centers. 
 
Therefore a simple and reliable method of identifying patients who 
are at high risk obstructive sleep apnea and triaging them for prompt 
diagnosis and treatment is clinically relevant. 
  
                             
 
32 
 
POLYSOMNOGRAM OF PATIENT WITH 
CENTRAL SLEEP APNEA 
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POLYSOMNOGRAM OF PATIENT WITH APNEA 
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POLYSOMNOGRAM OF PATIENT WITH HYPOPNEA 
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POLYSOMNOGRAM REPRESENTING 
RESPIRATORY EFFORT REALATED AROUSALS 
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QUESTIONNAIRES: 
 Multiple tools in the form of questionnaires have been developed for 
screening populations for Obstructive sleep apnea. 
The Epworth sleepiness scale: 
 Used to assess excessive day time sleepiness 
The Berlin Questionnaire describes three categories: 
 Snoring 
 Sleepiness  
 Risk factors 
The American association of sleep medicine developed 10 item 
questionnaires to detect classic symptoms of OSA and a 6 item check list 
to identify patients who are at high risk for OSA. 
The American society of anesthesiologists created an OSA checklist with 3 
categories 
 Predisposing  physical characteristics 
 History of apparent airway obstruction during sleep 
 Somnolence 
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Peri-operative sleep apnea prediction score: 
Developed by Ramachandran et al. It is based on logistic regression 
analysis of surgical patient data it has nine elements:  
 Age,                                             
 Male gender,                                 
 Obesity, 
 Snoring, 
 Type 2 diabetes mellitus, 
 Hypertension, 
 Thick neck, 
 Mallampati class 3 or greater, 
 Reduced Thyromental distance. 
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EPWORTH SLEEPINESS SCALE  
        
Date _________ 
 
Name_______________________________________
___________ 
 
Date of Birth_________________  
 
 
How likely are you to doze off or fall asleep in 
the situations described below, in contrast to 
feeling just tired?  This refers to your usual way 
of life in recent times. 
 
Use the following scale to choose the most 
appropriate number for each situation: 
 
0 - Would never doze 
1 - Slight chance of dozing 
2 - Moderate chance of dozing 
3 - High chance of dozing 
 
 
Situation      
      Chance of dozing (out of 3) 
 
Sitting and reading  
       
   
Watching TV 
       
    
Sitting, inactive in a public place (eg. a 
theatre or a meeting)  
   
As a passenger in a car for an hour without a 
break 
     
Lying down to rest in the afternoon when 
circumstances permit 
  
Sitting and talking to someone   
       
Sitting quietly after a lunch without alcohol 
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Berlin Questionnaire 
 
1. Complete the following: 
 
Height: ______ Weight: ______ 
 
Age: ___Gender: ____M ____F 
 
2. Do you snore? 
_____ Yes 
_____ No 
 
_____ Don't know 
 
If you snore: 
 
3. Your snoring is… 
_____   Slightly louder than breathing 
_____   As loud as talking 
_____   Louder than talking 
  
_____   Very loud, can be heard in 
adjacent rooms 
 
4. How often do you snore? 
 
_____   Nearly every day 
_____   3-4 times a week 
 
_____   1-2 times a week 
_____   1-2 times a month 
  
_____   never or nearly never 
 
5. Has your snoring ever bothered other 
people? 
 
_____  Yes 
_____  No 
 
6. Has anyone noticed that you quit 
breathing during your sleep? 
_____   Nearly every day. 
_____   3-4 times a week 
 
_____   1-2 times a week 
_____  1-2 times a month 
_____   never or nearly never 
 
 
 
7. How often do you feel tired or 
fatigued after your sleep? 
 
_____   Nearly every day 
_____   3-4 times a week 
 
_____   1-2 times a week 
_____   1-2 times a month 
 
_____   never or nearly never 
 
8. During your wake time, do you 
feel tired, fatigued, or not up to 
par? 
_____   Nearly every day 
  
_____   3-4 times a week 
_____   1-2 times a week 
_____   1-2 times a month 
 
_____   never or nearly never 
 
9. Have you ever nodded off or fallen 
asleep while driving a vehicle? 
_____   Yes 
 
_____   No 
_____ If yes, how often does it 
occur?                                     
      Nearly every day. _____ 
3-4 times a week _____ 
1-2 times a week _____ 
1-2 times a month _____ 
never or nearly never 
 
10. Do you have high blood pressure? 
 
_____   Yes 
_____   No 
_____   Don't know 
 
BMI (Body mass index) = 
______________ 
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Scoring the Berlin Questionnaire 
The questionnaire consists of 3 categories related to the risk of 
having sleep apnea. Patients can be classified into High Risk or Low Risk 
based on their responses to the individual items and their overall scores in 
the symptom categories. 
Categories and Scoring: 
Category 1:  Items 2, 3, 4, 5, and 6; 
Item 2: if ‘Yes’, assign 1 point 
Item 3: if either of the last two options is the response, assign 1 point 
Item 4: if either of the first two options is the response, assign 1 point 
Item 5: if ‘Yes’ is the response, assign 1 point 
Item 6: if either of the first two options is the response, assign 2 points 
Add points. Category 1 is positive if the total score is 2 or more points. 
Category 2: items 7, 8, and 9. 
Item 7: if either of the first two options is the response, assign 1 point 
Item 8: if either of the first two options is the response, assign 1 point 
Item 9: if ‘Yes’ is the response, assign 1 point 
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Add points. Category 2 is positive if the total score is 2 or more points. 
Category 3 is positive if the answer to item 10 is ‘Yes’ or if the BMI of  
the patient is greater than 30 kg/m2. (BMI is defined as weight (kg) 
divided by height (m) squared, i.e.., kg/m2). 
High Risk: if there are 2 or more categories where the score is positive. 
Low Risk: if there is only 1 or no categories where the score is positive. 
Additional Question: item 9 should be noted 
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Name _________________________________ 
 
Height ___________ Weight _________ 
 
Age __________ Male / Female ___________ 
 
 
STOP-BANG Sleep Apnea Questionnaire 
 
STOP   
Do you SNORE loudly (louder than 
talking or loud Yes No 
enough to be heard through closed 
doors)?   
Do you often feel TIRED, fatigued, or 
sleepy during Yes No 
daytime?   
Has anyone OBSERVED you stop 
breathing during Yes No 
your sleep?   
Do you have or are you being treated for 
high blood Yes No 
PRESSURE?   
   
BANG   
BMI more than 35kg/m2? Yes No 
AGE over 50 years old? Yes No 
NECK circumference > 16 inches 
(40cm)? Yes No 
GENDER: Male? Yes No 
   
TOTAL SCORE   
 
High risk of OSA    : 5 - 8 
  
Intermediate risk of OSA  : 3 - 4 
 
Low risk of OSA     : 0 – 2 
Each one parameter carries one point 
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STOP-BANG QUESTIONNAIRE: 
The STOP-BANG Questionnaire was first developed in 2008 by 
Frances Chung. It is a simple easy to remember and self-reportable 
screening tool which includes four subjective and four demographic 
parameters: 
       S  - SNORING                          
       T  - TIREDNESS                       
       O  - OBSERVED APNEA    
       P  - PRESSURE (B.P) 
       B  - BMI 
       A  - AGE  
       N  - NECK CIRCUMFERENCE    
       G  - GENDER 
The STOP-BANG Questionnaire was originally validated to screen 
OSA in surgical patients. 
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REVIEW OF LITERATURE: 
Nagappa M, Liao P, Wong J, Auckley D, 
Ramachandran SK, Memtsoudis S, et al.   
Seventeen studies including 9,206 patients met criteria for the 
systematic-review. In the sleep clinic population, the sensitivity was 90%, 
94% and 96% to detect any OSA (AHI ≥ 5), moderate to severe OSA (AHI 
≥15), and severe OSA (AHI ≥30) respectively. The corresponding 
Negative Predictive Value was 46%, 75% and 90%. A similar trend was 
found in the surgical population. In the sleep clinic population, the 
probability of severe OSA with a STOP-Bang score of 3 was 25%. With a 
stepwise increase of the STOP-Bang score to 4, 5, 6 and 7/8, the 
probability rose proportionally to 35%, 45%, 55% and 75%, respectively. 
In the surgical population, the probability of severe OSA with a STOP-
Bang score of 3 was 15%.With a stepwise increase of the STOP-Bang 
score to 4, 5, 6 and 7/8, the probability increased to 25%, 35%, 45% and 
65%, respectively. 
GRACE BOYNTON Et al 
Among N=219 subjects (mean age 46.3 ± 13.9 [s.d.] years; 98 
[44.8%] males) the sensitivity of the STOP-BANG measured for an 
Apnea/Hypopnea index (AHI, events per hour of sleep) >5, >15, and >30 
was 82, 93, and 97% respectively. Corresponding negative predictive 
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values were 44, 87, and 96%. Specificities were comparatively low (48, 40, 
and 33%).The STOP-BANG    measured and STOP-BANG self-reported 
scores showed essentially equivalent test characteristics against 
polysomnography. 
F. Chung, R. Subramanyam, P. Liao1, E. Sasaki, C. Shapiro and Y. 
Sun 
The median age of 746 patients was 60 yr, 49% males, BMI 30 
kg/m2 and neck circumference 39 cm. OSA was present in 68.4% with 
29.9% mild, 20.5% moderate and 18.0% severe OSA. For a STOP-BANG 
score of 5, the odds ratio (OR) for moderate/severe and severe OSA was 
4.8 and 10.4, respectively.  For STOP-BANG 6, the Odd’s Ratio for 
moderate/severe and severe OSA was 6.3 and 11.6, respectively. For 
STOP-BANG 7 and 8, the OR for moderate/severe and   severe OSA was 
6.9 and 14.9, respectively. The predicted probabilities for moderate/severe 
OSA increased from 0.36 to 0.60 as the STOP-BANG score increased 
from 3 to 7 and 8. 
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STUDY DESIGN: 
A screening study 
INCLUSION CRITERIA: 
• Patients coming for preoperative assessment for elective surgeries. 
• Adult patients. 
• Both genders. 
• ASA class 1 and 2. 
• Patients who have given valid informed consent. 
EXCLUSION CRITERIA: 
• Patients not satisfying inclusion criteria. 
• Impaired ability to communicate (e.g., confusion, poor hearing or 
language barrier). 
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MATERIALS AND METHODS 
MATERIALS: 
• Sphygmomanometer 
• Stethoscope 
• Weighing machine 
• Height scale 
• Inch tape 
 
SOURCE OF DATA: 
Patients coming for preoperative assessment clinics at Govt. Kilpauk 
Medical   College Hospital,   Chennai between February 2018 and July 
2018 will be assessed for inclusion and exclusion criteria and will be 
included in the study after obtaining written informed consent. 
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SAMPLE SIZE: 98 
Sample size was determined based on the study “Validation of 
STOP-BANG Questionnaire as a screening tool for OSA in surgical 
populations” 
 
Study population   4200 
Prevalence (p)     43% 
Allowable margin error (d)  10% 
Sample size ( n)                  =   4*P*(1-P)/d2 
                                           =    98 
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METHODOLOGY 
Out of 25-30 new patients coming to preoperative assessment clinic, 
one participant will be selected by simple random sampling and the 
participant will be evaluated using STOPBANG Questionnaire containing 
four subjective and four demographic parameters and the patients are 
classified based on STOP-BANG score into 
0 – 2  Low risk of sleep apnea    
3 – 4    Intermediate risk of having sleep apnea    
5 – 8    High risk of having sleep apnea  
and the same participant will be subjected to Polysomnography and 
classified based on APNOEA HYPOPNEA INDEX (AHI) into 
Normal   -  AHI <5 
MILD  -  AHI 5-14 
Moderate  - AHI 15-29 
Severe - AHI 30 and above 
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STATISTICAL ANALYSIS: 
Descriptive statistics will be done for all data and reported in terms 
of mean values and percentages. Suitable statistical tests of comparison 
will be done. 
Using 2X2 contingency tables, following predictive parameters will 
be calculated: sensitivity and   specificity, positive predictive value (PPV) 
and negative predictive value (NPV). The data will be analyzed using 
SPSS version 16 and Microsoft Excel 2007.  
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1.  Age distribution 
Mean age of the study participants was 33.8 years and standard 
deviation was 12.7 years 
Age groups Number Percentage 
11-20 5 5.1 
21-30 48 49.0 
31-40 21 21.4 
41-50 6 6.1 
51-60 13 13.3 
>60 5 5.1 
Total 98 100 
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59; 60% 
39; 40% 
Gender 
Male Female
AGE 
Out of 98 participants many of them from age group 20-30 yrs. The 
total number of participants in the above age group is 48(49%) 
Mean age of study participants are 33.8 years 
Standard Deviation is 13.7 years 
2. Gender distribution 
Gender Number Percentage 
Male 59 60.2 
Female 39 39.8 
Total 98 100 
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GENDER 
Out of total study participants, 
Number of males are 59 (60.2%), 
Number of females are 39 (39.8%). 
3. Distribution of BMI and neck circumference among study participants  
Parameter Mean SD Min Max 
BMI 25.7 5.2 15.39 49.1 
Neck circumference 40.8 4.4 30 47 
 
BODY MASS INDEX (BMI) 
Minimum BMI of participant is 15.39 
Maximum BMI of participant is 49.1 
Mean BMI of participants are 25.7 
Standard Deviation is 5.2 
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4. STOP-BANG score 
 
STOP-BANG score Number Percentage 
0 12 12.2 
1 21 21.4 
2 33 33.7 
3 6 6.1 
4 12 12.2 
5 7 7.1 
6 2 2.0 
7 5 5.1 
Total 98 100 
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All OSA 
5.  OSA (>5) 
All OSA Number Percentage 
≤5 75 76.5 
>5 23 23.5 
Total 98 100 
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Moderate or Severe OSA 
6. Moderate or severe OSA 
Moderate or Severe OSA Number Percentage 
≤15 86 87.8 
>15 12 12.2 
Total 98 100 
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Severe OSA 
6. Severe OSA 
Severe OSA Number Percentage 
≤30 91 92.9 
>30 7 7.2 
Total 98 100 
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7. Sensitivity, specificity, PPV and NPV of STOP-Bang score in 
determining all OSA   (AHI>5). 
 
Sensitivity  PPV NPV 
1 100 (86-100) 16 (9-26) 26.7 100 
2 100 (86-100) 44 (33-55) 35.4 100 
3 95.7 (79-99) 86.7 (77-93) 68.8 98.5 
4 95.7 (79-99) 94.7 (87-98) 84.6 98.6 
5 60.9 (41-78) 100 (95-100) 100 89.3 
6 30.4 (16-51) 100 (95-100) 100 82.4 
7 21.7 (10-42) 100 (95-100) 100 80.7 
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RESULTS 
For all OSA (AHI>5) 
For STOP BANG score of 3 for all OSA (AHI>5) sensitivity is 
95.7%and the corresponding NPV is 98.5% 
As the STOP BANG score increases from 2 to 3, 4, 5, 6, 7 
Specificity increases to 44%, 86.7%, 94.7%, 100%, 100%, and 100% 
respectively. 
 As the STOP BANG score increases from 2 to 3, 4, 5, 6, 7 
probability of OSA increases to 35.4%, 68.8%, 84.6%, 100%, 100%, and 
100% respectively. 
As the STOP BANG score increases 2 to 3, 4, 5, 6, 7 ;Negative 
predictive value show decreasing trend, the corresponding negative 
predictive values are 98.5, 98.6, 89.3, 82.4, 80.7. 
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8. Sensitivity, specificity, PPV and NPV of STOP-Bang score in 
determining moderate or severe OSA (AHI>15). 
 
STOP-BANG 
score 
Sensitivity Specificity PPV NPV 
1 100 (76-100) 14.0 (8-23) 14.0 100 
2 100 (76-100) 38.4 (29-50) 18.5 100 
3 100 (76-100) 76.7 (67-84) 37.5 100 
4 100 (76-100) 83.7 (75-90) 46.2 100 
5 91.7 (65-99) 96.5 (90-99) 78.6 98.8 
6 50 (25-75) 98.8 (94-100) 85.7 93.4 
7 41.7 (19-68) 100 (96-100) 100 92.5 
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STOP-BANG score 
Sensitivity and specificity of STOP-BANG score : Moderate or Severe 
OSA (AHI>15). 
Sensitivity Specificity
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RESULTS 
For Moderate to severe OSA (AHI>15)  
For STOP BANG score of 3 for all OSA (AHI>15)   sensitivity is 
100% and the corresponding NPV is 100% 
As the STOP BANG score increases from 2 to 3, 4, 5, 6, 7 
Specificity increases to 38.4%, 76.7%, 83.7%, 96.5%, 98.8%, and 100% 
respectively. 
As the STOP BANG score increases from 2 to 3, 4, 5, 6, 7 
Probability of OSA increases to 18.5%, 37.5%, 46.2%, 78.6%, 85.7%, and 
100% respectively. 
As the STOP BANG score increases from 2 to 3, 4, 5, 6, 7; Negative 
Predictive value show decreasing trends corresponding negative predictive 
values are 100% 
100%, 98.8%, 93.4%, 92.5%.  
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9. Sensitivity, specificity, PPV and NPV of STOP-Bang score in 
determining severe OSA (AHI>30). 
 
STOP-Bang 
score 
Sensitivity Specificity PPV NPV 
1 100 (65-100) 13.2 (8-22) 8.1 100 
2 100 (65-100) 35.2 (26-45) 10.6 100 
3 100 (65-100) 71.4 (61-80) 21.1 100 
4 100 (65-100) 78 (69-85) 25.9 100 
5 100 (65-100) 91.2 (84-96) 46.7 100 
6 85.7 (49-97) 97.8 (92-99) 75 98.9 
7 71.4 (36-92) 99 (94-99.8) 83.3 97.8 
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STOP-BANG score 
Sensitivity and specificity of STOP-BANG score : Severe OSA 
(AHI>30). 
Sensitivity Specificity
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RESULTS 
For severe OSA (AHI>30) 
For STOP-BANG score of 3 for severe OSA (AHI>30), sensitivity 
is 100% and the corresponding NPV is 100%. 
As the STOP BANG score increases from 2 to 3 4, 5, 6, 7; 
Specificity increases to 35.2%, 71.4%, 78%, 91.2. %, 97.8%, 99% 
respectively. 
As the STOP BANG score increases from 2 to 3, 4, 5, 6, 7 
probability of OSA increases to 10.6%, 21.1%, 25.9%, 46.7%, 75%, and 
83.3% respectively. 
For STOP BANG score increases from 2 to 3, 4, 5, 6, 7 the 
corresponding  Negative predictive values are 100%, 100%, 100%, 98.9%, 
97.8%. 
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ROC CURVES 
The area under ROC curve for all OSA (AHI >5) is 0.98. 
The area under ROC Curve for moderate to severe OSA is 0.99. 
The area under ROC curve for severe OSA is 0.99. 
 
  
                             
 
71 
 
DISCUSSION 
In this study 98,preoperative patients were screened with STOP-
BANG Questionnaire for obstructive sleep apnea and confirmed with 
Polysomnography. Of the 98 participants, 23 participants were diagnosed 
to have obstructive sleep apnea. In systematic-review and meta-analysis 
conducted by Nagappa, Liao, Wong, Auckley, and Ramachandran, 
Memtsoudis, et al, as the STOP-BANG score cut off increased from 2 to ≥ 
7 for any OSA with AHI ≥5 Specificity increased from 40% to 98%. 
Similarly in this study, Specificity shows increasing trends from 44 % to 
100 %. In the same systematic-review  and meta- analysis, Sensitivity for 
STOP-BANG 3 for any OSA with AHI ≥ 5  is 84% and sensitivity  for 
STOP-BANG score 7 is 4% . As the systematic-review, this study also 
shows similar decreasing trend from 95.1% to 21.7% as the STOP-BANG 
score increased from 3 to 7. The Positive predictive values  increases from 
75% to 82% as the STOP-BANG score increases from 3 to 7 for any OSA 
with AHI ≥ 5  in the systematic-review and in this study, probability of  
OSA increased from  68.8%  to 100% respectively.  
In systematic-review and meta-analysis conducted by Nagappa, 
Liao, Wong, Auckley, and Ramachandran, Memtsoudis, et al as the STOP-
BANG score cut off increased from 2 to ≥ 7 for moderate to severe OSA 
with AHI ≥ 15, Specificity increased from 11% to 90 %. Similarly in this 
study, Specificity shows increasing trends from 76.7% to 100 %. In the 
same systematic-review and meta-analysis, Sensitivity  for  STOP-BANG  
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3 for  moderate to severe  OSA with AHI ≥ 15  is 90 % and sensitivity  for 
STOP-BANG score 7 is 4% . As the systematic-review, this study also 
shows similar decreasing trend from 100% to 41.7 % as the          STOP-
BANG score increased from 3 to 7. In systematic-review and meta-
analysis, conducted by Nagappa, Liao, Wong, Auckley, and 
Ramachandran, Memtsoudis, et al, as the STOP-BANG score cut off 
increased from 3 to ≥ 7 for severe OSA   AHI ≥ 30 Specificity increased 
from 28 % to 97 %. Similarly in this study Specificity shows increasing 
trends from 71.4 % to 99 %. In the same systematic-review and meta-
analysis, Sensitivity for STOP-BANG 3 for severe OSA with AHI > 30  is  
95 % and sensitivity  for  STOP-BANG score 7 is  6 % . As the systematic-
review, this study also shows similar decreasing trend from 100 (65% -
100% ) to 71.4 % (36% -92%) as the STOP-BANG score increased from 3 
to 7.Because of the high prevalence of undiagnosed and untreated OSA 
and its associated  problems simple and effective OSA screening tool is 
essential. This way of screening the patients is very important for 
perioperative team as often there is little time to complete a preoperative 
assessment of OSA with the standard diagnostic approach. The STOP-
BANG Questionnaire can satisfy this need given that it is a short, practical 
and straight forward test. This questionnaire can be completed within 
minutes with very high response rates               
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SUMMARY  
Obstructive sleep apnea is the most prevalent of sleep    disordered   
breathing. Obstructive sleep apnea affects 24% of men, 9% of women in 
the general population. An estimated 82% of men 92% of women with 
moderate to severe obstructive sleep apnea have not been diagnosed. 
In OSA repeated episodes of partial and complete collapse cause a 
reduction or total cessation of airflow during sleep resulting in oxygen 
desaturation and arousals from sleep. 
OSA is a serious condition that diminishes quality of life and  
is also  associated  with many  co-morbidities.  . The average life span of a 
patient with untreated OSA is reduce 
 
The Aim of  study is to   test the performance of STOP-BANG 
QUESTIONNAIRE for the diagnosis of Obstructive sleep apnea in 
preoperative patients. The objective of the study is to validate The STOP-
BANG QUESTIONNAIRE by using POLYSOMNOGRAPHY as a gold 
standard test. 
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Methodology - Out of 25-30 new patients coming to preoperative 
assessment clinic, one participant will be selected by simple random 
sampling and the participant will be evaluated using STOPBANG 
Questionnaire containing four subjective and four demographic parameters 
and the patients are classified based on STOP-BANG score into 
0 – 2  Low risk of sleep apnea    
3 – 4    Intermediate risk of having sleep apnea    
5 – 8    High risk of having sleep apnea  
and the same participant will be subjected to Polysomnography and 
classified based on APNOEA HYPOPNEA INDEX (AHI) into 
Normal       -  AHI <5 
MILD         -  AHI 5-14 
Moderate  - AHI 15-29 
Severe      - AHI 30 and above 
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The Results are the Mean age of study participants are 33.8 years 
and the Standard Deviation is 13.7 years. The Mean BMI of participants 
are 25.7 and the Standard Deviation is 5.2.The Mean Neck circumference 
of participants are 40.8 and the Standard deviation is 4.4.For STOP BANG 
score of 3 for any OSA (AHI>5), sensitivity is 95.7%.As the STOP BANG 
score increases from 2 to 7, probability of OSA increases from 35.4% to 
100% respectively. For STOP BANG score of 3 for Moderate to Severe 
OSA (AHI>15), sensitivity is 100%.As the STOP BANG score increases 
from 2 to 7, probability of OSA increases to 18.5% to 100% respectively. 
For STOP BANG score of 3 for Severe OSA (AHI>30), sensitivity is 
100% .As the STOP BANG score increases from 3 to 7, probability of 
OSA increases to 21.1% to 83.3% respectively. 
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CONCLUSION 
 This study has concluded that the STOP-BANG Questionnaire is a 
concise, effective and reliable tool for screening Obstructive sleep apnea in 
preoperative patients. It facilitates efficient allocation of resources in both 
diagnosing and treating previously unrecognized Obstructive sleep apnea. 
The probability of moderate to severe Obstructive sleep apnea increases in 
direct proportion to the STOP-BANG score which makes the 
Questionnaire an easily used tool for identifying patients at high risk for 
Obstructive sleep apnea. 
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INFORMED CONSENT FORM 
STUDY: “A STUDY VALIDATING STOP-BANG 
QUESTIONNARE AS SCREENING TOOL FOR OBSTRUCTIVE 
SLEEP APNOEA IN PREOPERATIVE PATIENTS” 
STUDY CENTRE    :   KILPAUK MEDICAL COLLEGE HOSPITAL 
PATIENT’S NAME : 
PATIENT’S AGE     : 
I.P NO                        : 
                        Patient may check ( √  ) these boxes 
 I confirm that I understood the purpose of the 
procedure for the above study. I have the opportunity 
to ask question and all my questions and doubts have 
been answered to my complete satisfaction                                                                   
 I understand that my participation in the study is 
voluntary and that I am free to withdraw at any time 
without giving reason, without my legal rights being 
affected.                                                                                                            
 I understand that the ethical committee members and 
the regulatory authorities will need not my 
permission to look at my health records, both in 
respect of the current study and any further research 
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that may be conducted in relation to it, even if I 
withdraw from the study I agree to this access. 
However, I understand that my identity will not be 
revealed in any information released to third parties 
or published, unless as required under the law.           
  I agree not to restrict the use of any data or results 
that arise from the study. I agree to take part in the 
above study and to comply with the instructions 
given during the study and faithfully co operate with 
the study team and to immediately inform the study 
staff if I suffer from any deterioration in my health or 
well being or any unexpected or unusual symptoms. 
 I hereby consent to participate in this study. 
 I hereby give permission to undergo complete 
clinical examination and diagnostic tests including 
hematological, biochemical, radiological tests. 
Signature / thumb impression:               
Patient’s name and address:                            Place:                     Date: 
Signature of the investigator: 
Study investigator’s name:                              Place:                     Date: 
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PARTICIPANTS” INFORMATION SHEET 
Investigator                      :     Dr.PRINCE J   
Name of the participant   : : - 
Title:   ”A STUDY VALIDATING STOPBANG QUESTIONNAIRE 
AS SCREENING TOOL FOR OBSTRUCTIVE SLEEP APNOEA IN 
PREOPERATIVE PATIENTS”. 
You are invited to take part in this research study. We have got 
approval from the IEC. You are asked to participate because you satisfy 
the eligibility criteria. 
What is the purpose of this research? 
In this study, the accuracy of STOP-BANG Questionnaire in 
screening patients for obstructive sleep apnoea and evaluation of   the   
relationship   between STOP-BANG SCORE and probability of OSA 
among preoperative patients is determined 
BENEFITS:  
By identifying patients with OSA in preoperative period, we can 
anticipate and prevent intra-operative and postoperative respiratory 
complications. 
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CONFIDENTIALITY: 
Patients who participated in the study and their details will be 
maintained confidentially and at any cost, those details will not be let out. 
RIGHT TO WITHDRAW: 
Patients will not be forced to complete the study. At any cost, in 
such circumstances the treatment will not be compromised. 
                                                                                  
                                      Signature of the investigator: 
                             
Signature/Thumb impression of the participant: 
 
Date:                                                                 
Signature of the investigator:  
Place:                
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